Ariel Ramirez-Labrada
8PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 13, 2026
Mutant calreticulin enables potent and selective CAR-T cell therapy in preclinical models of myeloproliferative neoplasms.Cecilia Pesini, Mario Gil-Bellido, Lorena S Millan
|Mar 28, 2025
Combination of exhaled volatile organic compounds with serum biomarkers predicts respiratory infection severity.Patricia Esteban, Santiago Letona-Gimenez, Maria Pilar Domingo
|Aug 29, 2024
Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer.Andrea Sesma, Julian Pardo, Dolores Isla
|Jul 22, 2024
In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors.Cecilia Pesini, Laura Artal, Jorge Paúl Bernal
|Mar 28, 2024
Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability.Alba Moratiel-Pellitero, María Zapata-García, Marta Gascón-Ruiz
|Jan 21, 2023
A Subset of PD-1-Expressing CD56bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer.Marta Gascón-Ruiz, Ariel Ramírez-Labrada, Rodrigo Lastra
Pageof 2
Frequent Collaborators
5 joint publications
Eva M Gálvez
5 joint publications
Julián Pardo
4 joint publications
Patricia Esteban
4 joint publications
María Pilar Domingo
2 joint publications
Dolores Isla
2 joint publications
Alfonso Yubero
1 joint publications
Cecilia Pesini
1 joint publications
Maykel A Arias
1 joint publications
Llipsy Santiago
1 joint publications
José Manuel Garcia-Aznar
